At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,089 enrolled
Drug / intervention
Telmisartan +1 moredrug
Likely dose
Telmisartan 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational Study to Evaluate the Effects of Twynsta Tablets (Telmisartan and Amlodipine FDC, q.d.) With Life Style Modifications on Blood Pressure, Quality of Life, and Other Risk Factors in Korean Patients With Hypertension
In Brief
An observational study evaluating Telmisartan and amlodipine for Hypertension. Completed, enrolled 2,089 participants across 55 sites.
Detailed Summary
This observational study is designed to evaluate the effects of Twynsta tablets with life style modifications on blood pressure, quality of life, and other risk factors in Korean patients with hypertension in a routine clinical practice setting.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2011
First PostedMar 2011
Primary CompletionJun 2014
TodayJul 2026
First PostedMar 16, 2011
Enrollment StartMar 1, 2011
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.3 years ago
Interventions
Telmisartandrug
Telmisartan 40mg or 80mg
amlodipinedrug
amlodipine 5mg or 10mg